- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| Do | LifeStance Q2 2026 slides: 94% EBITDA surge, raised outlook | 1 | Investing.com | ||
| Do | LifeStance Q2 2026 slides: profitability surges as margins expand | 1 | Investing.com | ||
| Do | LifeStance Health Group beats top-line and bottom-line estimates; raises FY26 outlook | 2 | Seeking Alpha | ||
| Do | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | 134 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 07.07. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | Goldman Sachs initiates Lifestance Health stock at neutral | 1 | Investing.com | ||
| 04.06. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.05. | Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now | 5 | Zacks | ||
| 12.05. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.05. | LifeStance Health Group prices secondary offering at $8.15 per share | 1 | Seeking Alpha | ||
| 08.05. | LifeStance Health prices secondary offering at $8.15 per share | 1 | Investing.com | ||
| 08.05. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 07.05. | LifeStance: Aktionäre wollen 35 Millionen Aktien platzieren | 1 | Investing.com Deutsch | ||
| 07.05. | LifeStance stockholders plan 35M share offering | 1 | Investing.com | ||
| 07.05. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Launch of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 07.05. | Lifestance forecasts $1.64B-$1.68B 2026 revenue while targeting mid-teens adjusted EBITDA margins by 2028 | 2 | Seeking Alpha | ||
| 07.05. | LifeStance hebt nach starkem ersten Viertel die Prognose an: Umsatz wächst um 21 % | - | Investing.com Deutsch | ||
| 07.05. | LifeStance Q1 2026 presentation: 21% revenue growth, guidance raised | 1 | Investing.com | ||
| 07.05. | LifeStance Health Group, Inc. Q1 Earnings Summary | 1 | RTTNews | ||
| 07.05. | LifeStance Health Group GAAP EPS of $0.04 beats by $0.03, revenue of $403.5M beats by $17.38M | 8 | Seeking Alpha |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,680 | +0,06 % | EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an | EQS-Ad-hoc: Fresenius SE & Co. KGaA / Schlagwort(e): Prognose / Gesamtjahr
Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,880 | +1,38 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,100 | -0,36 % | Ihre wichtigsten Termine: Spannende Zahlen von: Sony, Moderna, AbbVie, Eaton, ExxonMobil, Linde und Puma! | © Foto: picture alliance / CFOTO | CFOTOGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,300 | -3,24 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Carl Zeiss Meditec von 30 auf 28 Euro gesenkt und die Einstufung auf "Hold" belassen. Das Geschäftsjahr 2025/26 sei für Carl... ► Artikel lesen | |
| TELADOC HEALTH | 5,838 | +0,48 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 70,14 | +0,43 % | Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 42,920 | +0,37 % | Weekly Buzz: Cipla, Viatris Win FDA Nod; Boston Scientific Cuts Jobs; argenx Snaps Up Forte Biosciences; Johnson & Johnson, GSK Strike Deals | NEW BRUNSWICK (dpa-AFX) - The healthcare sector delivered another eventful week, marked by major regulatory approvals, strategic partnerships, acquisitions, restructuring initiatives and significant... ► Artikel lesen | |
| DEXCOM | 72,00 | -0,28 % | Insulet sends Tandem, DexCom lower after guidance cut | ||
| ALIGN TECHNOLOGY | 148,80 | +1,33 % | Align Technology To Add Three Directors And Raise 2026 Share Repurchases To Up To $500 Million | ||
| INMODE | 12,910 | -1,41 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| PETMED EXPRESS | 1,697 | -0,47 % | PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited | DELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds" or the "Company") (Nasdaq: PETS) today confirmed that its Board of Directors (the "Board") has received an unsolicited... ► Artikel lesen | |
| TANDEM DIABETES | 17,000 | +3,66 % | Tandem Diabetes Q2 2026 slides: PayGo model drives margin expansion | ||
| INSULET | 121,70 | +0,66 % | Insulet Corp. Q2 Profit Advances | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released earnings for its second quarter that Increases, from the same period last yearThe company's earnings totaled $95.0 million, or $1.37 per... ► Artikel lesen | |
| ORGANON | 11,630 | -1,06 % | Organon: $81 Million Jada Gain Lifts GAAP Profit 68% As Adjusted Earnings Fall 29% |
LIFESTANCE HEALTH GROUP INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,010 (-0,09 %) liegt der Kurs bei 10,650 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFESTANCE HEALTH GROUP INC finden Sie auf Wallstreet Online.